期刊文献+

辛伐他汀治疗非酒精性脂肪性肝炎的疗效观察 被引量:3

在线阅读 下载PDF
导出
摘要 目的观察辛伐他汀对非酒精性脂肪性肝炎肝功能指标的影响。方法将42例非酒精性脂肪性肝炎患者随机分为对照组和观察组,观察组给予辛伐他汀片(10 mg/d)治疗,对照组给予葡醛内酯治疗,治疗1个月后观察两组患者的丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)的变化情况。结果两组患者转氨酶水平在治疗1个月后明显下降,观察组下降程度优于对照组,未发现肝功能恶化的病例。结论辛伐他汀可以降低非酒精性脂肪性肝炎患者的转氨酶水平,其疗效可靠、安全。
作者 符恒
出处 《内科》 2014年第6期677-678,共2页 Internal Medicine
  • 相关文献

参考文献8

  • 1无,宓余强,施军平,范建高.脂肪性肝病诊疗规范化的专家建议[J].中华肝脏病杂志,2013,21(9):652-655. 被引量:41
  • 2Riley P, AL Bakir M, O'Donohue J, et al. Prescribing statins to patients with nonalcoholic fatty liver disease:real cardio- vascular benefits outweigh theoretical hepatotoxic risk [ J ]. Cardiovasc THer, 2009,27 (3) : 216 - 220.
  • 3范建高.中国非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中国医学前沿杂志(电子版),2012,4(7):4-10. 被引量:276
  • 4韩春凤.他汀类药物临床应用进展[J].菏泽医学专科学校学报,2014,26(3):73-75. 被引量:2
  • 5Heart Protection Study Collaborative Group. MRC/BIqF heart protection study of cholesterol lowering with simvas- tatin in 5693 people with diabetes: a randomized placebo controlled trial [ J ] . Lancet, 2002, (360) : 2005 - 2016.
  • 6Pederson TR, Kjekshus J, Pyorala K, et al. Effects of simvas- tatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study [ J]. AmJ Cardlol, 1998, ( 81 ) : 333 -335.
  • 7刘思纯,马博.非酒精性脂肪性肝病的治疗[J].新医学,2010,41(7):478-481. 被引量:3
  • 8Thomas H, Frazier MD, Abigail M, et al. Treatment of alco- holic liver disease[ J]. Adv Gastroentero1,2011,4( 1 ) :63 - 81.

二级参考文献38

  • 1Fan, Jian-Gao,Peng, Yong-De.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):572-578. 被引量:42
  • 2范建高.糖尿病与肝病的关系及其诊治对策[J].中华糖尿病杂志,2009,1(4). 被引量:30
  • 3Lok AS;McMahon BJ.Chronic hepatitis B:update of recommendations[J],2004(03).
  • 4American Gastroenterological Association.American Gastroenterological Association medical position statement:nonalcoholic fatty liver disease[J]Gastroenterology,2002(05):1702-1704.
  • 5Farrell GC;Larter CZ.Nonalcoholic fatty liver disease:from steatosis to cirrhosis[J]Hepatology,2006(2 Suppl 1):S99-S112.
  • 6de Alwis NM;Day CP.Non-alcoholic fatty liver disease:the mist gradually clears[J]Journal of Hepatology,2008(Suppl 1):5104-5112.
  • 7Fan JG;Falrell GC.Epidemiology of non-alcoholic fatty liver disease in China[J]Journal of Hepatology,2009(01):204-210.
  • 8Farsell GC;Chitturi S;Lau GK.Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region:executive summary[J]Journal of Gastroenterology and Hepatology,2007(06):775-777.
  • 9Grattagliano I;Portincasa P;Palmieri VO.Managing nonalcoholic fatty liver disease:recommendations for family physicians[J]Canadian Family Physician,2007(05):857-863.
  • 10Eckel RH;Grundy SM;Zimmet PZ.The metabolic syndrome[J]The Lancet.

共引文献317

同被引文献45

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部